the isolates, we were interested by a new actinomycete strain belonging to the genus Streptosporangium and producing a new compound (R2) identified as a new angucyclinone. This paper describes the isolation, structure elucidation and antimicrobial activities of compound R2.
Details on the isolation and the taxonomy of the producing organism Streptosporangium sp. Sg3 were described in a previous paper. 11 To isolate compound R2, Streptosporangium sp. Sg3 was cultivated at 30 1C for 9 days in Erlenmeyer flasks (500 ml) containing 100 ml of ISP2 broth (yeast extract 4 g, malt extract 10 g, glucose 4 g, in 1 l distilled water, pH 7.2) on a rotary shaker (250 r.p.m.). The cultures (8 l) were centrifuged and filtered to remove mycelium. The culture filtrate was extracted with an equal volume of n-butanol to generate a crude extract (1.9 g). The latter was fractionated by size exclusion chromatography on Sephadex LH-20 (75% MeOH in H 2 O), resulting in five fractions, I-V. Fraction IV including R2, was of red color and exhibited an antibacterial activity. It was subjected to semipreparative reversed-phase HPLC using an Interchim UP5ODB column (250Â7.8 mm) (Interchim, Montluçon, France) and developed using a continuous grade from 20 to 75% MeOH in H 2 O (UV detection at 220 nm), yielding three active fractions (1, 2, 3). The major peak 2 with the main antibacterial activity was subjected to repeated HPLC to yield 3.5 mg of compound R2.
Compound R2 was obtained as a red powder (optical rotation [a] D 21 +56 (c 0.11, MeOH). The ESI-MS spectrum contained an ion peak at m/z 475.1 [M-H] À , and its molecular formula was determined by HRESI-MS analysis as C 26 H 19 O 9 (calcd 475.43 for (M-H) À , found 475.43). The UV absorption maximum at 535 nm was because of the red color and suggested a quinone chromophore. Absorptions at 3259, 2949 and 1721 cm À1 in the IR spectrum of R2 were characteristic of hydroxy, methyl and carbonyl groups, respectively. R2 was soluble in MeOH and DMSO, and insoluble in chloroform, n-hexane and H 2 O.
The structure of R2 (Figure 1) was determined by 1 H and 13 C NMR spectroscopy and by using 1 H-1 H COSY45, 1 H-13 C HMQC and 1 H-13 C HMBC experiments. The 1 H and 13 C chemical shifts of compound R2 are given in Table 1 . The 13 C and Heteronuclear SingleQuantum Correlation spectra showed 26 carbon signals with a large number of quaternary carbons (17 out of 26). From the 13 C data, it was possible to discern two keto-carbonyl groups (dc 188.4 and 186.5), one carboxylic acid group (dc 174.1), 19 sp 2 -hybridized carbons (dc from 160.2 to 114.7), two sp 3 -hybridized carbons bearing an electronegative heteroatom (dc 73.0 and 72.5), one sp 3 -hybridized carbon (dc 22.6) and two methyl groups (dc 22.4 and 12.4). In CD 3 OD, the 1 H NMR spectrum revealed two ortho-coupled aromatic protons (d H 7.82 and 7.66, 2H, J¼7. show any correlation in the HMBC spectrum (C1, C7a, C14 and C15). Their assignment has been confirmed by comparison with NMR data of the pradimicin antibiotic family. 12 The peak of the four enol or carboxylic acid protons was too broad to give HMBC correlations and so could not be exactly assigned. The observed coupling constant of 10.7 Hz between H5 and H6 suggested that the dihedral angles between H5 and H6 are near 1801 and is consistent with a trans-diaxal orientation. This value is similar with ones found for related compounds 3,12 where a 5S,6S absolute configuration has been deduced.
The structure of R2 was determined to be a benzo[a]naphtacene-2-carboxylic acid,4,7,11,12-tetrahydro-1,5,6,9,14-pentahydroxy-8,13-dioxo-3-methyl-10-ethyl.
The minimum inhibitory concentrations (MICs) of R2 were determined by a conventional agar dilution method using nutrient agar medium. Compound R2 showed strong activity against the Gram-positive bacteria Micrococcus luteus ATCC 9314 and Bacillus subtilis ATCC 6633 (MICs¼0.5 and 1 mg ml À1 , respectively), and moderate activity against Staphylococcus aureus CIP 7625 (MIC¼10 mg ml À1 ). A weak activity was observed against Listeria monocytogenes CIP 82110 and Mycobacterium smegmatis ATCC 607 (MICs¼40 and 50 mg ml À1 , respectively). Compound R2 showed no activity (MICs4100 mg ml À1 ) against the Gram-negative bacteria (Escherichia coli ATCC 10536 and Pseudomonas fluorescens number 412), the fungi (Mucor ramannianus NRRL 1829 and Aspergillus carbonarius number M333) and the yeasts (Saccharomyces cerevisiae ATCC 4226 and Candida albicans number 224).
In conclusion, from the results presented in this paper, we found that strain Streptosporangium sp. Sg3 produces a new angucyclinone that displayed antibacterial activities. 
